Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-978-9 | CAS number: 112-50-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Study period:
- 1984
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Methodology is valid for screening purposes. A single dose is selected from a screening study that is designed to produce maternal toxicity with mortality in the range 5-20% being deemed acceptable. Three key end points are percent viable litters, pup peri/postnatal survival (dead births) and pup body weight gain. The exposure period was 2 days shorter than recommended by current OECD guideline 414. Rationale for weight of evidence approach using read across substances is described in the overall section summary. Rationale for weight of evidence approach using read across substances is described in the overall section summary.
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 984
- Reference Type:
- publication
- Title:
- Evaluation of 60 chemicals in a preliminary developmental toxicity test.
- Author:
- Hardin DB, Schuler RL, Burg JR et al
- Year:
- 1 987
- Bibliographic source:
- Teratogen, carcinogen Mutagen 7:29-48
Materials and methods
Test guideline
- Qualifier:
- according to
- Guideline:
- other: Chernoff Kavlock assay.
- Deviations:
- not applicable
- Principles of method if other than guideline:
- Pregnant mice are treated during organogenesis and the number of live pups, birth and growth and survival to 2-3 days of age are monitored. Test is a screen to identify candidates for further testing. Interpretation of results from this assay are as follows using 6 key end points from the following:
Mild developmental toxicity indicated by effects on litter size, pup weight, survival, or weight gain,
Potential teratogen indicated by litter size <8 pups (mean or reduced post natal survival (<80%
Fetotoxicity indicated by reduced postnatal weight gain (<30% in 5 days) and no reduction in survival.
Fetuses were not examined for defects. - GLP compliance:
- no
- Limit test:
- yes
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- - Physical state: liquid
- No further data.
- Purity: >99%
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Labs, Wilmington MA, specified pathogen free.
- Age at study initiation: 6-8 weeks
- Housing: Individual (5 per cage during acclimation). Solid bottomed cages. Bedding used of a type known not to induce microsomal enzymes (Bed-O-Cobs, Sani-chip, San-i-cel or sterilized white wood shavings). Changed once per week but not after GD17.
- Diet: Commercial chow (either BP nutrition rat mouse breeder diet no 3, Purina chow no 5002 or Zeigler Brothers NOH-07 diet) available ad libitum.
- Water: untreated tap water, available ad libitum
- Acclimation period: 5 days. Underweight mice discarded.
ENVIRONMENTAL CONDITIONS
- No data.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: Distilled water
- Details on exposure:
- VEHICLE
- Justification for use and choice of vehicle: distilled water
- Amount of vehicle (if gavage): 10ml/kg. - Analytical verification of doses or concentrations:
- not specified
- Details on mating procedure:
- - Time mated
Day 1 defined as when copulatory plug observed. Mice received pre-mated on or before GD1-3. - Duration of treatment / exposure:
- GD 7-14
- Frequency of treatment:
- Daily.
- No. of animals per sex per dose:
- 50
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: previous rangefinder study (5 doses) on non pregnant animals to select an LD10 over an 8 day dosing period.
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Twice daily from GD18.
DETAILED CLINICAL OBSERVATIONS: not examined
BODY WEIGHT: Yes
- Time schedule for examinations: GD 7, 18 and day 3 post partum. Weight on GD 7 used to calculate dose for whole of study period. - Ovaries and uterine content:
- not examined
- Fetal examinations:
- - Litters removed within 12 hrs of delivery and number of live and still born pups recorded. Litter weight recorded. Pups returned to dam and then parameters remeasured after 48hrs.
- External examinations: No
- Skeletal examinations: No
- Head examinations: No - Statistics:
- Body weight data by analysis of variance. Proportion of surviving dams giving birth to viable litters by Fisher Irwin exact test. Number of live and stillborn pups, percent survival by analysis of variance and Student’s t test.
- Indices:
- no data
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:yes
Details on maternal toxic effects:
14% mortality. (Target dose level set to produce 10%). This level of mortality confirms study as valid. Mortality in control group was 0.
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:yes
Details on embryotoxic / teratogenic effects:
See table below:
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Effect level:
- ca. 5 500 mg/kg bw/day
- Basis for effect level:
- other: embryotoxicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Details of embryotoxic/teratogenic effects
Test group | Control | |
Viable litters | 32/33 (97%)* | 31/32 (97%) |
Number of live pups/litter at birth (average) | 10 | 10 |
Number of dead pups/litter | 0 | 0.1 |
Pup post natal survival | 98% | 100% |
Pup weight gain (days 1 -3 post partum) | 0.9g | 0.4g |
Pup birth weight | 1.6g | 1.5g* |
* statistically significantly different. However, the small percentage difference (~6%) may be of questionable biological significance.
Applicant's summary and conclusion
- Conclusions:
- A screening test shows no potential developmental toxicity (embryotoxicity) but at very high dose levels.
- Executive summary:
2 -(2 -ethoxyethoxy)ethanol when administered by gavage to pregnant female mice during GD7-14 at a dose level of 5500mg/kg causes no significant embryotoxicity. Parameters unaffected compared to controls include litter viability, pups per litter, number of dead pups, pup survival and pup weight gain. Pup weight at birth was statistically significantly reduced, but since this change was only 6%, it is of limited biological significance. On the basis of this screening study, it was concluded that this substance was a low priority for further developmental toxicity studies and that developmental toxicity is not an important characteristic of this substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live2